Paul MacDonaldInovio PharmaceuticalsINOCOMMENTMay 09, 2023

It is too small and volatile.

Paul MacDonald

Unknown

Unlock Rating

$0.84

Stock price when the opinion was issued

$0.97

As of Jul 24, 2026. Market Open.

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

It's a spec stock that hasn't delivered.

RISKY

A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.

Most Recent Experts

Andrew Pink

LDIC

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Paul MacDonaldInovio PharmaceuticalsINOCOMMENTMay 09, 2023

You might be interested:

Inovio Pharmaceuticals(INO)

Inovio Pharmaceuticals(INO)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals